In a recent blog, we asked “what do we really know about COVID-19’s impact on essential health services?” In that blog, our focus was primarily on what international partners were doing to monitor the effects of COVID-19 on essential health services. What we didn’t highlight is the increasingly detailed evidence emerging from countries themselves, which paints a varied picture of national policy responses to the pandemic and the impacts of those responses.
CGD Policy Blogs
The COVID-19 pandemic has cost lives and disrupted economic activity worldwide. It has impacted government budgets globally by reducing tax receipts and increasing spending on programs to save lives and transfer income to those adversely affected by the pandemic.
This blog and the accompanying CGD Policy Brief are a follow-up to the 2019 “Health Taxes Save Lives” report by the Task Force on Fiscal Policy for Health co-chaired by Michael Bloomberg and Lawrence Summers.
In 2020, epidemiological modelling went from relative obscurity to being central in helping governments, and the public, understand COVID-19 as it spread around the world. In 2021, with the emergence of effective COVID-19 vaccines, Health Technology Assessment (HTA) will be critical to making the best possible decisions in bringing the pandemic under control, particularly in low-and middle-income countries (LMICs). In this blog we look at the potential of HTA to inform how much vaccine countries should buy, who should pay, and how vaccines can be most effectively delivered.
In this blog, we describe some major global efforts that examine whether essential health services have been disrupted during the pandemic, summarize what they tell us, and highlight some of the remaining gaps in our understanding and knowledge.
Expanding Health Product Manufacturing in Africa: Ideas for Development Finance Institutions, Procurers, and Policymakers
In October 2020, the Center for Global Development—in partnership with African Union Development Agency-NEPAD (AUDA-NEPAD), UN Economic Commission for Africa (UNECA), and the African Leaders Malaria Alliance—hosted a high-level roundtable on regional health product manufacturing in Africa. This blog is based on the authors’ reflections of the roundtable.
Drugs created with billions in government support, bought almost exclusively by governments and international agencies are shrouded in secrecy: who is paying how much for delivery of what by when is a matter of guesswork and estimate.
Prior to the pandemic, many low-and middle-income countries were on track to expand Universal Health Coverage. To what extent can LMICs still make real progress as their economies enter some of the most severe recessions in centuries?
We Can Stop Preventable COVID Deaths by Urgently Prioritising Medical Oxygen and Essential Critical Care
The COVID-19 pandemic is a critical illness crisis, with more than two million deaths worldwide and hospitals overburdened with 67 percent of COVID-19 admissions requiring oxygen. With the emergence of new variants and the rise of second or third epidemic waves, there is unprecedented demand for oxygen as a life-sustaining, first-line therapeutic and an essential resource when caring for the critically ill.
Following the UK government’s decision to cut aid from 0.7 to 0.5 percent of GNI, recent announcements have shown that bilateral aid is likely to receive the biggest hit, all while in the midst of a global pandemic.